Beranda › Kanker Paru › Minnesota › Brooklyn Park
Uji klinis Kanker Paru di Brooklyn Park, MN
10 studi untuk Kanker Paru mencari peserta di lokasi sekitar Brooklyn Park (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
- Minnesota Oncology - Coon Rapids, Coon Rapids · 4 mi jauhnya
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauhnya
- dan 2 lainnya
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Menerima pesertaFase 3
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauhnya
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Menerima pesertaFase 3
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Allina Health Cancer Institute - Mercy Hospital, Coon Rapids · 4 mi jauhnya
- Minnesota Oncology Hematology, P.A., Coon Rapids · 4 mi jauhnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- Minnesota Oncology Hematology PA, Coon Rapids · 4 mi jauhnya
- North Memorial Health Cancer Center, Robbinsdale · 4 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauhnya
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Menerima pesertaStudi observasional
- Mercy Hospital, Coon Rapids · 4 mi jauhnya
- North Memorial Medical Health Center, Robbinsdale · 4 mi jauhnya
- Fairview Lakes Medical Center, Wyoming · 24 mi jauhnya
- dan 1 lainnya
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Brooklyn Park
- Kanker Paru Non-Sel Kecil10 studi
- Kanker Kolorektal7 studi
- Kanker Prostat6 studi
- Leukemia Mieloid Akut6 studi
- Kanker Payudara6 studi
- Kanker Endometrium5 studi
- Melanoma5 studi
- Kanker Ginjal (Karsinoma Sel Renal)4 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
- Kanker Ovarium4 studi
- Leukemia Limfositik Kronis4 studi
- Kanker Kolon4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.